Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of prior transarterial chemoembolization on response to immune checkpoint inhibitor treatment in patients with hepatocellular carcinoma.

Clinical and molecular hepatology·2026
Same author

Chimeric antigen receptor therapy for hepatocellular carcinoma.

Seminars in immunology·2026
Same author

Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

Journal for immunotherapy of cancer·2025
Same author

Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

Cancer letters·2025
Same author

[New immunotherapy approaches for gastrointestinal cancer].

Die Gastroenterologie·2025
Same author

Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer.

JHEP reports : innovation in hepatology·2025

Related Experiment Video

Updated: Feb 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.5K

Does CSF1R Blockade Turn into Friendly Fire?

Tim F Greten1

  • 1Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Cancer Cell
|November 15, 2017
PubMed
Summary
This summary is machine-generated.

Colony-stimulating factor 1 receptor (CSF1R) blockade depletes tumor-associated macrophages but unexpectedly increases polymorphonuclear cells. This occurs due to cancer-associated fibroblasts releasing Cxcl-1, impacting anti-tumor immunity.

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.9K

Related Experiment Videos

Last Updated: Feb 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.5K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.9K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment.
  • Colony-stimulating factor 1 receptor (CSF1R) signaling is crucial for TAM development and function.
  • Targeting CSF1R is a therapeutic strategy to modulate anti-tumor immunity.

Purpose of the Study:

  • To investigate the comprehensive effects of CSF1R blockade on immune cell infiltration in tumors.
  • To elucidate the mechanisms underlying unexpected immune cell accumulation during CSF1R inhibition.
  • To understand the role of cancer-associated fibroblasts (CAFs) in modulating immune responses to CSF1R blockade.

Main Methods:

  • Utilized mouse models of cancer treated with CSF1R inhibitors.
  • Performed detailed immune cell profiling using flow cytometry and single-cell RNA sequencing.
  • Analyzed cytokine and chemokine expression in tumor tissues and isolated CAFs.

Main Results:

  • CSF1R blockade led to the expected depletion of tumor-associated macrophages.
  • An unexpected accumulation of tumor-infiltrating polymorphonuclear cells was observed.
  • Cancer-associated fibroblasts were identified as a source of Cxcl-1, a chemokine driving polymorphonuclear cell recruitment.

Conclusions:

  • CSF1R blockade has complex and dual effects on the tumor immune microenvironment.
  • The recruitment of polymorphonuclear cells by Cxcl-1 from CAFs may counteract the benefits of TAM depletion.
  • These findings highlight the need to consider CAF-mediated signaling in the design of CSF1R-targeted therapies.